<DOC>
	<DOCNO>NCT01390480</DOCNO>
	<brief_summary>In placebo control study investigator aim investigate effect vitamin D supplementation subject new onset type 1 diabetes immunological , endocrine metabolic parameter .</brief_summary>
	<brief_title>Effects Vitamin D Supplementation Subjects With New Onset Type 1 Diabetes</brief_title>
	<detailed_description>This bicentric , randomize placebo control , double blind study , aim evaluate effect vitamin D supplementation subject new onset type 1 diabetes immunological , endocrine metabolic parameter . The primary study goal evaluate influence vitamin D supplementation number function master regulatory T-cells control condition within 13 month . The secondary study goal comprehensive immune phenotyping determine whether Vit D produce change consistent general improvement immune homeostasis support ß-cell tolerating intervention , assessment ß-cell function subject obtain preliminary data effect Vit D ß-cell survival .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>male female &gt; 6 year new onset type 1 diabetes ( 3 month ) pregnancy hypercalcemia ( &gt; 2,65 mmol/L ) chronic disease include longterm medication 4 week per year ( except type 1 diabetes )</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>Autoimmune disease</keyword>
	<keyword>diabetes</keyword>
</DOC>